Infoblox Reports Fourth Quarter and Fiscal Year 2016 Results
Aug 31, 2016 20:10 pm UTC| Business
SANTA CLARA, Calif., Aug. 31, 2016 -- Infoblox (NYSE:BLOX), the network control company, today reported its financial results for its fourth fiscal quarter and fiscal year ended July31, 2016. Total net revenue for the...
Ollie’s Bargain Outlet Holdings, Inc. Announces Fiscal 2016 Second Quarter Financial Results
Aug 31, 2016 20:10 pm UTC| Business
HARRISBURG, Pa., Aug. 31, 2016 -- Ollie’s Bargain Outlet Holdings, Inc. (NASDAQ:OLLI) (“Ollie’s” or the “Company”) today announced financial results for the second quarter ended July 30, 2016. Second Quarter Summary: ...
OncoMed Management to Present at Two Upcoming Investment Conferences
Aug 31, 2016 20:10 pm UTC| Business
REDWOOD CITY, Calif., Aug. 31, 2016 -- OncoMed Pharmaceuticals, Inc. (NASDAQ:OMED) a clinical development-stage biopharmaceutical company focused on discovering and developing novel anti-cancer stem cell and...
A-Mark Precious Metals Acquires Majority Stake in SilverTowne Mint
Aug 31, 2016 20:05 pm UTC| Business
SANTA MONICA, Calif., Aug. 31, 2016 -- A-Mark Precious Metals, Inc. (NASDAQ:AMRK), a full-service precious metals trading company and an official distributor for all the major sovereign mints, has acquired a majority...
Rightside® to Participate at the 2016 Deutsche Bank Technology Conference on September 13, 2016
Aug 31, 2016 20:05 pm UTC| Business
KIRKLAND, Wash., Aug. 31, 2016 -- Rightside Group, Ltd. (Nasdaq:NAME), a leading provider of domain name services that advance the way businesses and consumers define and present themselves online, today announced that...
Medigus Announces Second Quarter 2016 Financial Results
Aug 31, 2016 20:05 pm UTC| Business
OMER, Israel, Aug. 31, 2016 -- Medigus Ltd. (NASDAQ:MDGS) (TASE:MDGS), a medical device company developing minimally invasive endosurgical tools and a leader in direct visualization technology, today announced financial...
TRACON Pharmaceuticals to Present at Upcoming Investment Conferences
Aug 31, 2016 20:05 pm UTC| Business
SAN DIEGO, Aug. 31, 2016 -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, wet age-related...